Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function | Patent Number 10525057

US 10525057 B2
Application Number14034727
Publication NumberUS 20150087654 A1
Pendency6 years, 3 months, 16 days
Filled DateSep 24, 2013
Priority DateSep 24, 2013
Publication DateMar 26, 2015
Expiration DateSep 23, 2033
Inventor/ApplicantsArash Raoufinia
ExaminesHENLEY III, RAYMOND J
Art Unit1629
Technology Center1600
Assignments
Otsuka Pharmaceutical
Current
Otsuka PharmaceuticalOtsuka Holdings Co. Ltd.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.